Publicaciones en colaboración con investigadores/as de Second University of Naples (17)

2024

  1. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort

    Schizophrenia Research, Vol. 266, pp. 237-248

  2. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies

    Translational Psychiatry, Vol. 13, Núm. 1

2022

  1. Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC

    ESMO Open, Vol. 7, Núm. 3

2021

  1. Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 4, pp. 273-284

  2. Spontaneous ARIA-like events in cerebral amyloid angiopathy–related inflammation a multicenter prospective longitudinal cohort study

    Neurology, Vol. 97, Núm. 18, pp. E1809-E1822

2020

  1. How mental health care should change as a consequence of the COVID-19 pandemic

    The Lancet Psychiatry, Vol. 7, Núm. 9, pp. 813-824

2019

  1. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis

    Arthritis and Rheumatology, Vol. 71, Núm. 9, pp. 1553-1570

2018

  1. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

    Arthritis and Rheumatology, Vol. 70, Núm. 11, pp. 1829-1834

  2. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227

2017

  1. Update of EULAR recommendations for the treatment of systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 8, pp. 1327-1339

2014

  1. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey

    Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 5, pp. 666-672

  2. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2013

  1. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1747-1755

  2. 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Arthritis and Rheumatism, Vol. 65, Núm. 11, pp. 2737-2747

2012

  1. Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

    Arthritis Care and Research, Vol. 64, Núm. 3, pp. 351-357

2008

  1. Phylogenetic analysis of viridans group streptococci causing endocarditis

    Journal of Clinical Microbiology, Vol. 46, Núm. 9, pp. 3087-3090